CURE Pharmaceutical Holding Corp.: CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins

New Marketing Programs Showing Encouraging Early ResultsSHERMAN OAKS, CA / ACCESSWIRE / November 22, 2022 / CURE Pharmaceutical Holding Corp. (OTCQB:CURR) ("CURE" or the "Company"), a proprietary broad

Related Keywords

Hanover ,Niedersachsen ,Germany ,New York ,United States ,Florida ,California ,Robertj Costantino ,Rob Costantino ,Kostenloser Wertpapierhandel ,Gerald Bagg ,Nancy Duitch ,Nicole Kidman ,Rob Davidson ,Quigley Simpson Inc ,Holding Corp View ,Twitter ,Sera Labs Inc ,Hanover International Inc ,Holding Corp ,Audit Committee ,Walmart Stores ,Exchange Commission ,Facebook ,New Marketing Programs Showing Encouraging Early ,Seratopical Revolution ,Cure Pharmaceutical ,Sera Labs ,Brand Ambassador ,Wealth Oct ,Powerful Impact ,Beauty Market Revealed ,Corporate Governance ,Chief Financial Officer ,Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Cure ,Harmaceutical ,Molding ,Orp ,Reports ,Third ,Quarter ,022 ,Results ,Ith ,Strong ,Sequential ,Ear ,Dover ,Revenue ,Increases ,Ontinued ,Thigh ,Margins ,